The present invention relates to a combination comprising (a) an adenosine A2a receptor agonist as defined herein and (b) an adrenergic 2 receptor agonist, for simultaneous, sequential or separate administration by the inhaled route in the treatment of an obstructive airways or other inflammatory disease.

 
Web www.patentalert.com

< Treatment of balance impairments

< Method of preparing modified cellulose ether

> Esters

> Combination for the treatment of endothelial damage

~ 00226